English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA new study by a University of Arkansas information systems researcher and his colleague at the University of Waikato in New Zealand shows that COVID vaccine trials conducted in geographic locations with low infection rates had higher efficacy results, compared to trials in locations with high infection rates.
Tag: VACCINE TRIAL
NAU’s Pathogen and Microbiome Institute to test Allarity Therapeutics drug as potential therapy for new, highly infectious Coronavirus Variant B117
The testing plan for the “British variant” is based on findings of pre-clinical tests showing stenoparib blocks infection and the replication of SARS-CoV-2, as recently published in peer-reviewed journal mBio.
Rutgers Black Physician Shares Why She Joined Coronavirus Vaccine Clinical Trial
As the United States begins rolling out coronavirus vaccines, many people, especially those in the Black community, are still hesitant to participate when it becomes widely available. Valerie Fitzhugh, a Rutgers doctor discusses why she chose to participate in a coronavirus vaccine trial as a Black woman, wife, and mother of two children and encourages more people, particularly minorities, to be vaccinated.
UCLA to lead statewide coalition to address COVID-19’s impact on communities at risk
A coalition of 11 academic institutions and their community partners across California has received a $4.1 million grant from the NIH for a statewide community-engaged approach to addressing COVID-19 among populations that have been disproportionately affected by the pandemic.
Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials
As researchers race to develop a COVID-19 vaccine, a Rutgers infectious disease expert and a Rutgers bioethicist discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials and what a successful vaccine may mean.